The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
wei lai yao pin shi chang cheng gong chan pin yu ce
Author(s): 
Pages: 250-251
Year: Issue:  4
Journal: World Clinical Drugs

Keyword:  脓毒症扎来普隆阿洛司琼抗癫痫药多非利特泮托拉唑性功能障碍蛋白磷酸激酶产品计划乙酸胆碱酯酶;
Abstract: 为了能不断推出新产品,医药公司正纷纷增加研究和开发经费的投入。然而哪些产品将能立足未来药品市场?American Home Products公司拥有最坚实的产品开发计划,其研制的抗婴幼儿耳炎疫苗及Rapamune(西罗莫司sirolimus),Sonata(扎来普隆,zaleplon)和Protonix(泮托拉唑,pantoprazole)都将在市场获得成功。其它可能获得成功的优选者当推Bristol-Myers Squibb公司的ACE抑制剂omapatrilat,Eli Lilly公司的治疗性功能障碍的IC-351,Glaxo Wellcome公司的Seretide以及Warner-Lam
Related Articles
No related articles found